HLS Therapeutics Inc. earnings per share and revenue

HLTRF earnings per share for the last quarter are -0.19 USD whereas the estimation was -0.16 USD which accounts for -19.72% surprise. Company revenue for the same period amounts to 12.47 M USD despite the estimated figure of 14.56 M USD. Estimated earnings per share for the next quarter are -0.15 USD, and revenue is expected to reach 14.36 M USD. Also watch annual changes over time to get a bigger picture of HLTRF earnings per share and revenue dynamics.